CRNX Exercise Disclosure
Struthers Richard Scott · SEC Form 4 · Filed Aug 11, 2026
Exercise
Calculated transaction value
$99.98K
Struthers Richard Scott President & CEO
CRNX
Transaction date
Aug 7, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 4 days later
CRNX daily price context
Close on/before transaction
$84.08
Aug 7, 2026
Close before public filing
$84.15
Aug 10, 2026
Return since public filing
+0.95%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,422 shares @ $22.61
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-055700
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$399.99K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $99.98K |
| Crinetics Pharmaceuticals, Inc. CRNX Current | Exercise | Aug 7, 2026 | $99.98K |
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $100.03K |
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $100K |
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $0 |
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $0 |
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $0 |
| Crinetics Pharmaceuticals, Inc. CRNX | Exercise | Aug 7, 2026 | $0 |